TFRC and hepatocellular carcinoma: Conversely, TFR1 overexpression increased cell viability, an effect that was attenuated by co-treatment with deferoxamine (DFO), indicating that TFR1 promotes hepatoma cell viability by elevating intracellular iron levels (Figure 5D).